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Abstract
Background: Post-operative pancreatic fistula (POPF) is one of the most fearful complications which
may occur after pancreaticoduodenectomy (PD). The methods used to predict POPF pre-operatively have
not been studied in great detail. We analyzed correlation between various parameters related to PD
including pre-operative magnetic resonance imaging (MRI) signal intensity (SI), pathology of pancreatic
fibrosis and occurrence rates of POPF, and verified that MRI SI results could be the determining values
for pre-operative prediction of POPF.
Methods: From January 2005 to August 2006, we retrospectively examined 43 cases of PDs by
reviewing abdominal MRI findings, degree of fibrosis of remnant pancreatic stump, and other surgery-
related parameters.
Results: POPF encountered in PD were 11 cases (25.6%). Operation time and degree of fibrosis of
remnant pancreatic cut surface were related to POPF (P = 0.030, P = 0.010). The pancreas–liver SI ratio
(PLSI) between fistula group and no fistula group was -0.0009  0.2 and -0.1297  0.2, respectively (P
= 0.0004). The pancreas–spleen SI ratio (PSSI) in each group was 0.423  0.25 and 0.288  0.32,
respectively (P = 0.014). Using quantitative analysis, the SI ratios were 1.27 and 0.66 in each group (P =
0.013).
Conclusions: When analyzing the results of POPF in 43 patients who underwent PD, PLSI, PSSI and
qualitative analysis, fistula group differed significantly from no fistula group. Using these results, it will be
helpful for us to predict the occurrence of POPF pre-operatively using MRI in PD patients.
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Introduction
Pancreaticoduodenectomy is now the standard operative proce-
dure for both benign and malignant lesions of the pancreas and
periampullary region.1,2 Besides the difficulties in surgical tech-
niques, post-operative complications of PD are very important.
Even although recent advances in surgical techniques and peri-
operative management have drastically reduced morbidity and
mortality rates after PD, post-operative pancreatic fistula (POPF)
remains one of the most fatal complications after PD.3–12 Several
factors predisposing to the development of POPF have been sug-
gested. Old age, a narrow pancreatic duct diameter, soft or normal
pancreatic parenchyma, ampullary or duodenal disease, longer
operation time, greater intra-operative blood loss and lower sur-
gical volume have been regarded as possible causes of POPF.3–5,13–25
Even although countless studies were done about POPF, there are
no prominent strategies in predicting POPF before it occurs.
According to previous reports, magnetic resonance imaging
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(MRI) has played an important role in the evaluation of pancre-
atic parenchyma.26 At 1.5 T, a T1 weighted image (T1WI) typically
shows the pancreas having higher signal intensity (SI) than all the
other tissues in the abdomen, including the liver and spleen. Com-
paring the SI of the pancreas and the liver was enough to differ-
entiate a normal from an abnormal pancreas.26–30 We postulate
that pancreatic parenchymal evaluation with the use of breath-
hold unenhanced fat-suppressed T1WI could relate to POPF after
PD because of its potential to predict pancreas parenchymal con-
dition. To our knowledge, there is no report regarding the rela-
tionship between pre-operative MRI and POPF. In the present
study, we retrospectively reviewed various pre-operative param-
eters of 43 patients who underwent PD and pre-operative MRI.
We performed this study to evaluate the accuracy in predicting
POPF using of non-enhanced fat-suppressed T1W MRI, and MR
data were compared with real pancreatic parenchymal condition.
Materials and methods
Patients
This study was approved by our institutional review board for
human investigation. From January 2005 to August 2006, 60 con-
secutive patients who underwent PD were enrolled in this study.
Among the 60 patients, 17 were excluded because they did not
undergo MRI (n = 10) or they had a MRI at another hospital (n =
7). The final study population consisted of 43 patients including
18 (42%) patients with bile duct cancer, 3 (6.8%) patients with
pancreatic cancer, 18 (42%) patients with ampullay cancer, 1
(2.3%) patient with chronic pancreatitis, 1 (2.3%) patient with
intraductal papillary mucious neoplasm (IPMN), 1 (2.3%)
patient with transverse colon cancer and 1 (2.3%) patient with a
duodenal gastrointestinal stromal tumor (GIST). All patients
underwent pre-operative MRI. The mean interval between MRI
and PD was 3.5 days (range of 1–7 days). They included 26 men
and 17 women, with an age range of 28–80 years (mean, 61.7
years). The types of PD were: Whipple’s operation in 29 patients,
pylorus preserving pancreaticoduodenectomy (PPPD) in 13
patients and hepatopancreaticoduodenectomy (HPD) in 1
patient. Since the beginning of the study period, the most relevant
patient- and surgery-related data were entered prospectively into a
computerized database. For the purpose of this study, we reviewed
the medical records, MRI and histopathologic results and ana-
lyzed these results retrospectively.
MRI technique and analysis
All MR examinations were performed with 1.5-T superconduct-
ing magnets (Sonata; Siemens, Erlangen, Germany) using a torso
multicoil array. Breathhold unenhanced fat-suppressed gradient
echo (GRE) T1WIs were obtained with a TR of 125 ms, a TE of
2.52 ms, and a flip angle of 70°. The matrix size was 256 ¥ 192.
Section thickness was 7 mm for an acquisition time ranging from
28 to 30 s. Fat suppression was used. In quantitative analysis, all SI
measurements were performed by one investigator (D.H.C.), who
was blinded to the clinical findings and the results of other
imaging tests. Standard regions of interests (ROI) were made with
an area of 20–45 mm2. Three SI measurements were obtained in
the body and tail of the pancreas which was the residual portion
after PD. An average of three measurements was also obtained
from the liver and spleen and used as comparison tissue.
Pancreas–liver SI ratio (PLSI) and pancreas–spleen signal inten-
sity ratio (PSSI) were calculated as follows: pancreas to compari-
son tissue SI ratio = [(SI pancreas/SI comparison tissue) - 1]. In
qualitative analysis, the examinations were all reviewed on a work-
station (Leonardo, SiemensMedical System, Forcheim,Germany).
Every examination was analyzed by an experienced radiologist
(J.H.K.) who was blinded to the clinical history of the patient
and the results of the quantitative analysis. The pancreas SI was
qualitatively assessed relative to liver and spleen SI tissue using a
five-point scale, as follows: -2 = hypointense compared with the
spleen, -1 = same intense as the spleen, 0 = intense between the
liver and spleen, 1 = same intense as the liver, 2 = hyperintense
compared with the liver (Fig. 1).
Surgical technique and post-operative care
All operations were performed by a team of four surgeons spe-
cialized in hepatobiliary and pancreatic surgery. The standard,
pylorus-preserving resection involved division of the duodenum
2 cm distal to the pylorus with resection of all of the duodenum
distal to the transection site, removal of the gallbladder and
common bile duct (proximal to the level of the cystic duct junc-
tion), resection of the head, neck and uncinate process of the
pancreas and removal of the periampullary lesion. For Whipple’s
operation, a distal gastrectomy varying from 20% to 40% was
performed. In the case of macroscopically suspected margins,
frozen sections for these margins were also performed. An
end-to-side duct to mucosa type pancreaticojejunostomy was
performed. Further downstream, an end-to-side hepaticojejunos-
tomy and side-to-side gastroenterostomy or an end-to-side
duodenojejunostomy were made. At the end of the operation,
drains were left in the area of the pancreaticojejunostomy and the
hepaticojejunostomy. All patients were managed according to a
standard post-operative pathway. All patients received H2 blocker
during the entire post-operative hospital course, and octreotide
treatment was continued for 7 days after the operation. We
checked the fluid volume and amylase concentration from drains
on post-operative days 1, 3, 5, 7, and 10.
For the definition of POPF, we made reference to the Interna-
tional Study Group on pancreatic fistula.3,31
We defined POPF using a combination of the following: drain-
age of more than 50 ml of fluid with amylase content greater than
three times the upper normal serum value using surgically placed
drains on post-operative day 10, or pancreatic anastomotic dis-
ruption demonstrated by a radiograph, with or without the
presence of patient’s clinical symptoms [peritoneal tenderness,
progressive abdominal pain, body temperature > 38.5°C, leukocy-
tosis (white blood cell > 15 000/l)].
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Pathologic analysis (assessment of fibrosis in
pancreatic stump)
The tissues of the pancreatic stump obtained during surgery were
fixed in formalin, dehydrated and embedded in paraffin. The pan-
creatic tissues that indicated a mirror image of the pancreatic
stump anastomosed with jejunum were post-operatively pro-
cessed with hematoxylin and eosin (H&E) and Masson’s
trichrome staining for accurate estimation of the degree of fibro-
sis. Every examination was analyzed by an experienced pathologist
(S.Y.J) who was blinded to the clinical history or radiologic results
of any of the patients. The degree of fibrosis was categorized by
intralobular fibrosis and interlobular fibrosis compared with the
normal pancreas. Each type was assessed by the criteria of Klopper
and Maillet32 into two categories: weak, i.e. fibrosis of degree 0 to
3 and heavy, i.e. degree 4 to 6. The sum of degrees of each fibrous
type represented the grade of fibrosis in the pancreatic stump of
each patient (Fig. 2).
The degree of fatty infiltration in the parenchyma of the pan-
creatic stump was estimated as 0 (absent), 1 (mild, 1–5%), 2
(moderate, 6–20%) and 3 (marked, >20%).
Statistical analysis
Statistical analysis was performed using the SPSS software (SPSS v.
12.0; SPSS Inc., Chicago, IL, USA). Continuous variables were
analyzed using the unpaired, independent, two-tailed t-test. Con-
tinuous data are reported as the mean  standard deviation. The
c2-square test was used for univariate analysis of categorical data.
Receiver-operating characteristic (ROC) curves were constructed
to establish the optimal cut-off value of MR parameters in pre-
dicting POPF. Sensitivity and specificity were calculated in accor-
dance with standard methods. A P-value of less than 0.05 was
considered statistically significant.
Results
Among the 43 patients who underwent PD, POPF was present in
11 patients (25.6%). The demographics and general characteris-
tics are summarized in Table 1. In the pre-operative period, sero-
logic test, liver function tests and total bilirubins were abnormal,
and tumor markers were also elevated, but, in general, no labora-
tory test proved to be related to POPF. Table 2 shows parameters
related to operation between the fistula and no fistula group. The
type of operation, amount of blood loss, hospital days and pan-
creatic duct size showed no significant relationship to POPF.
Among these parameters we investigated, only the operation time
was related to POPF (P = 0.030). Table 3 showed MR parameters
between the fistula group and no fistula group. In the PLSI ratio
using MRI, the value of the PLSI ratio in patients in the fistula
Figure 1 Pancreas grading in the pre-operative fat suppressed MRT1WI. Pancreatic signal intensity (SI) was qualitatively assessed relative
to the liver and spleen SI using a five-point scale. When the pancreas SI was higher than the liver, it was defined as Grade 2, Grade 1 was
defined as a SI of the pancreas and spleen. When the pancreas SI was between the liver and spleen, it was defined as Grade 0, Grade -1
means a pancreatic SI equal to the spleen, and in Grade -2 pancreas SI was lower than the spleen. (a) Grade 2, (b) Grade 1, (c) Grade 0,
(d) Grade -1, (e) Grade -2
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group was -0.1297  0.2, whereas the value of the PLSI ratio in
patients in the no fistula group was -0.0009 0.2 (P = 0.0004). In
the PSSI ratio using MRI, the value of the PSSI ratio in patients
in the fistula group was 0.423  0.25, whereas the value of the
PSSI ratio in patients in the no fistula group was 0.288  0.32
(P = 0.014). In qualitative analysis using MRI, the score in patients
within the fistula group was -1.27, whereas the score in patients
within the no fistula group was 0.66 (P = 0.013). In mean pancreas
Figure 2 Hematoxylin and eosin (H&E) staining and Masson's
Trichrome staining of the normal pancreas. (a) H&E stain, (b) Mas-
son's Trichrome stain. Fibrosis grading of the pancreas. Pancreatic
fibrosis was graded from 0 (none) to 6 (severe) according to the
severity of fibrosis, and was divided into intralobular fibrosis and
interlobular fibrosis. The sum of each scoring was from grade 0 to
grade 12. (c) Mild intralobular fibrosis in H&E stain, (d) mild intral-
obular fibrosis in Masson's stain, (e) severe intralobular fibrosis in
H&E stain, (f) severe intralobular fibrosis in Masson's stain, (g) mild
interlobular fibrosis in H&E stain, (h) mild interlobular fibrosis in
Masson's stain, (i) severe interlobular fibrosis in H&E stain and (j)
severe interlobular fibrosis in Masson's stain (Original magnification
a–j: ¥100)

Table 1 Demographics and general considerations of the patients
Fistula
n = 11
No fistula
n = 32
P value
Gender
Male 5 (45.5)a 21 (65.6) NS
Female 6 (54.5) 11 (34.4)
Mean age (years) 61.9 61.5 NS
Pathology
Pancreatic cancer 0 (0) 3 (9.4) NS
Bile duct cancer 6 (54.5) 12 (37.6) NS
Ampullary cancer 5 (45.5) 13 (40.6) NS
IPMN 0 (0) 1 (3.1) NS
Chronic pancreatitis 0 (0) 1 (3.1) NS
Transverse colon cancer 0 (0) 1 (3.1) NS
Duodenal GIST 0 (0) 1 (3.1) NS
Laboratory values
Mean hemoglobin (g/dl) 12.1 12.1 NS
Mean albumin (g/dl) 3.7 3.6 NS
Mean BUN (mg/dl) 13.2 14.0 NS
Mean creatinine (mg/dl) 0.7 0.7 NS
Mean AST (U/l) 104.2 124.3 NS
Mean ALT (U/l) 152.3 174.8 NS
Mean LDH (U/l) 412.8 436.3 NS
Mean total bilirubin (mg/dl) 4.5 7.4 NS
Mean CA19-9 (U/ml) 601.7 342.8 NS
aValues in parentheses are percentages
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fibrosis using pathology, the score in patients within the fistula
group was 2.36  1.36, whereas the score in patients within the
no fistula group was 4.56  3.98 (P = 0.010). Figure 3 shows
diagnostic performance for preoperative predictions of POPF
with each MR parameter. The diagnostic performance for pre-
operative predictions of POPF was better with the qualitative
analysis (Az = 0.653) than with the PLSI ratio (Az = 0.640) and
PSSI ratio (Az = 0.613); although, there was no statistically sig-
nificant difference in each MR parameter. The optimal cut-off
value between fistula group and no fistula group on each MR
parameters was -0.12097 in the PLSI ratio (sensitivity = 36%,
specificity = 89%), 0.29979 in the PSLSI ratio (sensitivity = 79%,
specificity = 45%) and 0.5 in qualitative analysis (sensitivity =
91%, specificity = 34%) using the ROC curve.
Discussion
POPF is still the ‘Achilles heel’ of the PD. Even at tertiary care
hepatobiliary centers, leakage rates at the pancreaticojejunostomy
are over 10%. A wealth of surgical literature has been devoted to
various technical aspects of PD. Before the 1980s, mortality rates
of 20% were common, and morbidity rates were even higher. The
most frequent source of major morbidity after PD is leakage at the
site of pancreatic anastomosis: this most often results in peri-
pancreatic fluid collection, abscess, development of a pancreatic
fistula or bleeding from adjacent major vessels. Countless
methods have been described to reduce POPF rates, including
descriptions of various anastomotic techniques, the use of exter-
nal stenting for the pancreatic duct, reinforcement of anastomosis
with fibrin glue or with round ligament, using the surgical micro-
scope and occluding of the pancreatic duct.11,23–25,33–38What is clear
from the literature is that numerous techniques may be associated
with low rates of POPF and that the occurrence of POPF reliably
relates to several predominant factors. The texture of the pancreas
and size of the pancreatic duct seem to be major risk factors for
Table 2 Parameters related to operation
Fistula
n = 11
No fistula
n = 32
P-value
Name of operation
Whipple's operation 6 (54.5)a 23 (68.8) NS
PPPD 5 (45.5) 8 (25.1) NS
HPD 0 (0) 1 (3.1) NS
Other operative parameters
Mean operation time (min) 492.0 565.2 0.030
Mean blood loss (ml) 960.0 1037.5 NS
Mean hospital days 26.3 36.9 NS
Mean P-duct size (mm) 3.5 4.6 NS
Mean CBD size (mm) 14.4 14.0 NS
aValues in parentheses are percentages
Table 3 Correlation between post-operative pancreatic fistula (POPF) and signal intensity (SI) ratio by fat suppressed MRT1WI compared
with pancreatic fibrosis grade
Fistula No fistula P-value
Pancreas–liver SI ratio (PLSI) -0.0009  0.2 -0.1297  0.2 0.0004
Pancreas–spleen SI ratio (PSSI) 0.423  0.25 0.288  0.32 0.014
Qualitative analysis 1.27 0.66 0.013
Mean pancreas fibrosis (grade) 2.36  1.36 4.56  3.98 0.010
Figure 3 The diagnostic performance for the pre-operative predictions of post-operative pancreatic fistula (POPF). The Az values (area under
the ROC curve) of the PLSI ratio, PSSI ratio and qualitative analysis were 0.640 (95% CI: 0.529–0.751), 0.613 (95% CI: 0.507–0.719) and
0.653 (95% CI: 0.548–0.759), respectively. (a) Receiver operating characteristics (ROC) curve of the PLSI, (b) ROC curve of the PSSI and
(c) ROC curve of the qualitative analysis
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POPF. A small pancreatic duct and soft pancreatic texture are
consistently associated with higher POPF rates, presumably
because smaller ducts make the anastomosis inherently more
technically challenging.When the pancreas is soft and fragile, even
an atraumatic needle causes a small leakage of pancreatic juice. It
is also likely that a more normal pancreas has a higher output of
pancreatic enzymes. However, these parameters which are related
to a pancreatic fistula can usually be determined during surgery or
the post-operative period. No studies have shown the prediction
of a pancreatic fistula pre-operatively. If only it becomes predict-
able, it will be very helpful for surgeons pre-operatively.More care
will be taken when operating on the so-called ‘high-risk group’. In
the present study, the focus was on finding out the predictive
factors for POPF using MR parameters compared with fibrosis of
the pancreas stump.
Recently, pre-operative MRI has been adapted as a routine
diagnostic tool for periampullary lesions as a result of its non-
invasiveness and a lot of diagnostic information. MRI has also
played an important role in the evaluation of pancreatic paren-
chyma. Fat-suppressed techniques are now available to decrease
chemical shift, truncation and breathing artifacts and to improve
dynamic range. Good quality breathhold sequences and
increased spatial resolution can be obtained using the torso mul-
ticoil array. The normal pancreas shows hyperintense relative to
all other solid abdominal tissues on T1WI in multiple studies. In
abnormal pancreatic parenchyma, the pancreatic parenchymal SI
decreased. This is caused by pancreatic atrophy, fibrosis, edema
and fat infiltration.26,27,30 Breathhold unenhanced fat-suppressed
T1WI offers excellent potential for depicting POPF.26–30 In our
study, MR parameters including PLSI, PSSI and qualitative
analysis showed significant relationships with pancreatic
fistula. These MR parameters can predict pancreatic fistula
before PD. Even although there was no statistical significance,
the qualitative analysis showed the best performance. So we
can apply these methods in predicting the possibility of POPF
pre-operatively.
Most studies described that a soft pancreas caused more POPF
than a hard pancreas. In our study, pancreatic fibrosis grading
assessed using the criteria of Klopper and Maillet32 was related to
POPF. Furthermore, fat content in the pancreatic stump was not
related to POPF (data not shown), indicating that pancreatic
fibrosis is closely related to POPF which was mentioned in pervi-
ous reports in the literature.
There were some limitations to this study. First, even although
we showed potent possible relationships between POPF and
various MR SI ratios, we still do not have perfect methods to
prevent a pancreatic fistula after PD. However, recently, several
brand new surgical techniques using omental flap or round liga-
ment of the liver for pancreaticojejunostomy protection have
been reported.11,15,23–25,33–38 These techniques could be applied to
so-called ‘high-risk patients’ in terms of MRI PLSI, PSSI and
qualitative analysis of pancreas parenchyma. Second, the case
number was relatively small and study was designed retrospec-
tively. Therefore, a prospective large-scale study should be done.
Third, the pancreatic fibrosis index which was calculated
in the pancreatic stump tissue could not represent the whole
pancreas.
In conclusion, the MRI PLSI, PSSI and qualitative analysis of
pancreas parenchyma were definitely related to POPF after PDs.
Using this result it will be helpful for us to predict the occurrence
of a pancreatic fistula pre-operatively in the future and to reduce
pancreatic fistula-related complications.
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